Daraxonrasib for Pancreatic Cancer: What’s Next?
Jul 09, 2026
View online
Daraxonrasib for Pancreatic Cancer: What’s Next?
WHO Calls for Urgent Action as New Cancer Cases Are Projected to Nearly Double by 2050
Katelyn Daniels։ Final Results of Venetoclax Combination Therapy in Relapsed or Refractory AML
Novartis’ $1.5B Myricx deal is a preclinical bet on a brand-new ADC payload
Jay Bhattacharya: America’s Understanding of Cancer Research is Far Better for Dr. Sharpless’s Service
Victor Moreno։ A Step Forward for Cell Therapy in Solid Tumors
Top 10 Pancreatic Cancer Updates – June 2026
FIFA World Cup and Cancer Awareness: How Football Can Promote Early Detection Worldwide
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA
ACOG Foundation 2026 Request for Grant Proposals
25th Annual International Congress on the Future of Breast Cancer West
APPOS Austin 2026
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
